H
Harapan Harapan
Researcher at Syiah Kuala University
Publications - 185
Citations - 7493
Harapan Harapan is an academic researcher from Syiah Kuala University. The author has contributed to research in topics: Medicine & Disease. The author has an hindex of 26, co-authored 127 publications receiving 3772 citations. Previous affiliations of Harapan Harapan include University of Western Australia.
Papers
More filters
Journal ArticleDOI
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.
Alfonso J. Rodriguez-Morales,Jaime A. Cardona-Ospina,Estefanía Gutiérrez-Ocampo,Rhuvi Villamizar-Peña,Yeimer Holguin-Rivera,Juan Pablo Escalera-Antezana,Lucia Elena Alvarado-Arnez,D. Katterine Bonilla-Aldana,Carlos Franco-Paredes,Andrés F. Henao-Martínez,Alberto Paniz-Mondolfi,Guillermo J. Lagos-Grisales,Eduardo Ramírez-Vallejo,José Antonio Suárez,Lysien I. Zambrano,Wilmer E. Villamil-Gómez,Graciela J. Balbin-Ramon,Ali A. Rabaan,Harapan Harapan,Kuldeep Dhama,Hiroshi Nishiura,Hiromitsu Kataoka,Tauseef Ahmad,Ranjit Sah +23 more
TL;DR: A systematic literature review with meta-analysis was performed using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases, finding that this virus brings a huge burden to healthcare facilities, especially in patients with comorbidities.
Journal ArticleDOI
Coronavirus disease 2019 (COVID-19): A literature review.
Harapan Harapan,Naoya Itoh,Amanda Yufika,Wira Winardi,Synat Keam,Haypheng Te,Dewi Megawati,Zinatul Hayati,Abram L. Wagner,Mudatsir Mudatsir +9 more
TL;DR: A literature review of publicly available information to summarize knowledge about the pathogen and the current epidemic is presented in this article, where the causative agent, pathogenesis and immune responses, epidemiology, diagnosis, treatment and management of the disease, control and preventions strategies are all reviewed.
Journal ArticleDOI
Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia
Harapan Harapan,Abram L. Wagner,Amanda Yufika,Wira Winardi,Samsul Anwar,Alex Kurniawan Gan,Abdul Malik Setiawan,Yogambigai Rajamoorthy,Hizir Sofyan,Mudatsir Mudatsir +9 more
TL;DR: Acceptance of a COVID-19 vaccine was highly influenced by the baseline effectiveness of the vaccine, and preparing the general population to accept a vaccine with relatively low effectiveness may be difficult.
Journal ArticleDOI
Remdesivir and its antiviral activity against COVID-19: A systematic review.
Andri Frediansyah,Andri Frediansyah,Firzan Nainu,Kuldeep Dhama,Mudatsir Mudatsir,Harapan Harapan +5 more
TL;DR: Although remdesivir has been used as a compassionate drug for treating COVID-19 patients, it has only moderate efficacy and more efficacy assessments are urgently warranted in clinical trials.
Journal ArticleDOI
Predictors of COVID-19 severity: a systematic review and meta-analysis
Mudatsir Mudatsir,Jonny Karunia Fajar,Jonny Karunia Fajar,Laksmi Wulandari,Gatot Soegiarto,Muhammad Ilmawan,Yeni Purnamasari,Bagus Aulia Mahdi,Galih Dwi Jayanto,Suhendra Suhendra,Yennie Ayu Setianingsih,Romi Hamdani,Daniel Alexander Suseno,Kartika Agustina,Hamdan Yuwafi Naim,Muchamad Muchlas,Hamid Hunaif Dhofi Alluza,Nikma Alfi Rosida,Mayasari Mayasari,Mustofa Mustofa,Adam Hartono,Richi Aditya,Firman Prastiwi,Fransiskus Xaverius Meku,Monika Sitio,Abdullah Azmy,Anita Surya Santoso,Radhitio Adi Nugroho,Camoya Gersom,Ali A. Rabaan,Sri Masyeni,Firzan Nainu,Abram L. Wagner,Kuldeep Dhama,Harapan Harapan +34 more
TL;DR: More than 30 risk factors are associated with a higher risk of severe COVID-19, and these may serve as useful baseline parameters in the development of prediction tools for CO VID-19 prognosis.